BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Way SS, Borczuk AC, Dominitz R, Goldberg MB. An Essential Role for Gamma Interferon in Innate Resistance to Shigella flexneri Infection. Infect Immun 1998;66:1342-8. [DOI: 10.1128/iai.66.4.1342-1348.1998] [Cited by in Crossref: 70] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Bernardini ML, Arondel J, Martini I, Aidara A, Sansonetti PJ. Parameters underlying successful protection with live attenuated mutants in experimental shigellosis. Infect Immun 2001;69:1072-83. [PMID: 11160004 DOI: 10.1128/IAI.69.2.1072-1083.2001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
2 Ullah H, Mahmud S, Hossain MJ, Islam MSB, Kibria KMK. Immunoinformatic identification of the epitope-based vaccine candidates from Maltoporin, FepA and OmpW of Shigella Spp, with molecular docking confirmation. Infect Genet Evol 2021;96:105129. [PMID: 34737105 DOI: 10.1016/j.meegid.2021.105129] [Reference Citation Analysis]
3 Jehl SP, Nogueira CV, Zhang X, Starnbach MN. IFNγ inhibits the cytosolic replication of Shigella flexneri via the cytoplasmic RNA sensor RIG-I. PLoS Pathog 2012;8:e1002809. [PMID: 22912573 DOI: 10.1371/journal.ppat.1002809] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
4 Gönci B, Németh V, Balogh E, Szabó B, Dénes Á, Környei Z, Vicsek T. Viral epidemics in a cell culture: novel high resolution data and their interpretation by a percolation theory based model. PLoS One 2010;5:e15571. [PMID: 21187920 DOI: 10.1371/journal.pone.0015571] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
5 Gazi MA, Das S, Mahfuz M, Hasan MM, Hossain MS, Fahim SM, Alam MA, Noor Z, Gilchrist CA, Petri WA, Rahman MM, Mazumder RN, Haque R, Sarker SA, Ahmed T. Screening for coeliac disease in children and adults living in a slum of Dhaka, Bangladesh. BMJ Open Gastroenterol 2019;6:e000294. [PMID: 31139429 DOI: 10.1136/bmjgast-2019-000294] [Reference Citation Analysis]
6 Vepachedu R, Karim Z, Patel O, Goplen N, Alam R. Unc119 protects from Shigella infection by inhibiting the Abl family kinases. PLoS One 2009;4:e5211. [PMID: 19381274 DOI: 10.1371/journal.pone.0005211] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
7 Ranallo RT, Kaminski RW, George T, Kordis AA, Chen Q, Szabo K, Venkatesan MM. Virulence, inflammatory potential, and adaptive immunity induced by Shigella flexneri msbB mutants.Infect Immun. 2010;78:400-412. [PMID: 19884336 DOI: 10.1128/IAI.00533-09] [Cited by in Crossref: 31] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
8 Burnaevskiy N, Fox TG, Plymire DA, Ertelt JM, Weigele BA, Selyunin AS, Way SS, Patrie SM, Alto NM. Proteolytic elimination of N-myristoyl modifications by the Shigella virulence factor IpaJ. Nature 2013;496:106-9. [PMID: 23535599 DOI: 10.1038/nature12004] [Cited by in Crossref: 103] [Cited by in F6Publishing: 92] [Article Influence: 11.4] [Reference Citation Analysis]
9 Chitradevi ST, Kaur G, Uppalapati S, Yadav A, Singh D, Bansal A. Co-administration of rIpaB domain of Shigella with rGroEL of S. Typhi enhances the immune responses and protective efficacy against Shigella infection. Cell Mol Immunol 2015;12:757-67. [PMID: 25640657 DOI: 10.1038/cmi.2014.86] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
10 McCaskey SJ, Rondini EA, Clinthorne JF, Langohr IM, Gardner EM, Fenton JI. Increased presence of effector lymphocytes during Helicobacter hepaticus-induced colitis. World J Gastroenterol 2012; 18(13): 1459-1469 [PMID: 22509077 DOI: 10.3748/wjg.v18.i13.1459] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
11 Helbig KJ, Teh MY, Crosse KM, Monson EA, Smith M, Tran EN, Standish AJ, Morona R, Beard MR. The interferon stimulated gene viperin, restricts Shigella. flexneri in vitro. Sci Rep 2019;9:15598. [PMID: 31666594 DOI: 10.1038/s41598-019-52130-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
12 Duménil G, Olivo JC, Pellegrini S, Fellous M, Sansonetti PJ, Nhieu GT. Interferon alpha inhibits a Src-mediated pathway necessary for Shigella-induced cytoskeletal rearrangements in epithelial cells. J Cell Biol 1998;143:1003-12. [PMID: 9817757 DOI: 10.1083/jcb.143.4.1003] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 1.8] [Reference Citation Analysis]
13 Edwards JA, Rockx-Brouwer D, Nair V, Celli J. Restricted cytosolic growth of Francisella tularensis subsp. tularensis by IFN-gamma activation of macrophages. Microbiology (Reading) 2010;156:327-39. [PMID: 19926654 DOI: 10.1099/mic.0.031716-0] [Cited by in Crossref: 43] [Cited by in F6Publishing: 49] [Article Influence: 3.3] [Reference Citation Analysis]
14 Martinez-Becerra FJ, Kissmann JM, Diaz-McNair J, Choudhari SP, Quick AM, Mellado-Sanchez G, Clements JD, Pasetti MF, Picking WL. Broadly protective Shigella vaccine based on type III secretion apparatus proteins. Infect Immun 2012;80:1222-31. [PMID: 22202122 DOI: 10.1128/IAI.06174-11] [Cited by in Crossref: 86] [Cited by in F6Publishing: 55] [Article Influence: 7.8] [Reference Citation Analysis]
15 Kuehl CJ, D'Gama JD, Warr AR, Waldor MK. An Oral Inoculation Infant Rabbit Model for Shigella Infection. mBio 2020;11:e03105-19. [PMID: 31964739 DOI: 10.1128/mBio.03105-19] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Arizmendi O, Kumar P, Zheng Q, Stewart JP, Picking WD, Picking W, Martinez-Becerra FJ. Vaccination With Mouse Dendritic Cells Loaded With an IpaD-IpaB Fusion Provides Protection Against Shigellosis. Front Immunol 2019;10:192. [PMID: 30800131 DOI: 10.3389/fimmu.2019.00192] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
17 Way SS, Borczuk AC, Goldberg MB. Thymic independence of adaptive immunity to the intracellular pathogen Shigella flexneri serotype 2a. Infect Immun 1999;67:3970-9. [PMID: 10417163 DOI: 10.1128/IAI.67.8.3970-3979.1999] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
18 Lu T, Das S, Howlader DR, Zheng Q, Ratnakaram SSK, Whittier SK, Picking WD, Picking WL. L-DBF Elicits Cross Protection Against Different Serotypes of Shigella spp. Front Trop Dis 2021;2:729731. [DOI: 10.3389/fitd.2021.729731] [Reference Citation Analysis]
19 Sidik SM, Salsman J, Dellaire G, Rohde JR. Shigella infection interferes with SUMOylation and increases PML-NB number. PLoS One 2015;10:e0122585. [PMID: 25848798 DOI: 10.1371/journal.pone.0122585] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
20 Amadou Amani S, Lang ML. Bacteria That Cause Enteric Diseases Stimulate Distinct Humoral Immune Responses. Front Immunol 2020;11:565648. [PMID: 33042146 DOI: 10.3389/fimmu.2020.565648] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Reis RS, Horn F. Enteropathogenic Escherichia coli, Samonella, Shigella and Yersinia: cellular aspects of host-bacteria interactions in enteric diseases. Gut Pathog 2010;2:8. [PMID: 20649986 DOI: 10.1186/1757-4749-2-8] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 3.6] [Reference Citation Analysis]
22 Mani S, Toapanta FR, McArthur MA, Qadri F, Svennerholm AM, Devriendt B, Phalipon A, Cohen D, Sztein MB. Role of antigen specific T and B cells in systemic and mucosal immune responses in ETEC and Shigella infections, and their potential to serve as correlates of protection in vaccine development. Vaccine 2019;37:4787-93. [PMID: 31230883 DOI: 10.1016/j.vaccine.2019.03.040] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
23 McCloskey MC, Shaheen S, Rabago L, Hulverson MA, Choi R, Barrett LK, Arnold SLM. Evaluation of in vitro and in vivo antibiotic efficacy against a novel bioluminescent Shigella flexneri. Sci Rep 2019;9:13567. [PMID: 31537849 DOI: 10.1038/s41598-019-49729-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
24 Toapanta FR, Bernal PJ, Kotloff KL, Levine MM, Sztein MB. T cell mediated immunity induced by the live-attenuated Shigella flexneri 2a vaccine candidate CVD 1208S in humans. J Transl Med 2018;16:61. [PMID: 29534721 DOI: 10.1186/s12967-018-1439-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
25 Ray S, Dasgupta AK. Probiotics as cheater cells: parameter space clustering for individualized prescription. J Theor Biol 2014;361:165-74. [PMID: 25066785 DOI: 10.1016/j.jtbi.2014.07.019] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
26 Smith DG, Mitchell SC, Nash T, Rhind S. Gamma interferon influences intestinal epithelial hyperplasia caused by Lawsonia intracellularis infection in mice. Infect Immun 2000;68:6737-43. [PMID: 11083789 DOI: 10.1128/IAI.68.12.6737-6743.2000] [Cited by in Crossref: 37] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
27 Seo GY, Giles DA, Kronenberg M. The role of innate lymphoid cells in response to microbes at mucosal surfaces. Mucosal Immunol 2020;13:399-412. [PMID: 32047273 DOI: 10.1038/s41385-020-0265-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
28 Shi ZX, Wang HL, Hu K, Feng EL, Yao X, Su GF, Huang PT, Huang LY. Identification of alkA gene related to virulence of Shigella flexneri 2a by mutational analysis. World J Gastroenterol 2003; 9(12): 2720-2725 [PMID: 14669321 DOI: 10.3748/wjg.v9.i12.2720] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
29 Schroeder GN, Hilbi H. Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion. Clin Microbiol Rev 2008;21:134-56. [PMID: 18202440 DOI: 10.1128/CMR.00032-07] [Cited by in Crossref: 365] [Cited by in F6Publishing: 197] [Article Influence: 26.1] [Reference Citation Analysis]
30 Philpott DJ, Edgeworth JD, Sansonetti PJ. The pathogenesis of Shigella flexneri infection: lessons from in vitro and in vivo studies. Philos Trans R Soc Lond B Biol Sci 2000;355:575-86. [PMID: 10874731 DOI: 10.1098/rstb.2000.0599] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 3.0] [Reference Citation Analysis]